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Glucocorticoids
are known to regulate the enzyme phenylethanolamine-N-methyltransferase (PNMT) in the adrenal medulla of the rat and are thereby thought to control the synthesis of epinephrine.
We have examined the details of this relationship in a simplified system, chromaffin cell primary cultures derived from bovine adrenal medulla. Cultured chromaffin cells were found to have a cytosolic, high affinity, saturable glucocorticoid-binding protein with the steroid specificity of a classical glucocorticoid receptor and a Kd of -1 nM. Treatment of cultured cells with dexamethasone or hydrocortisone at any time up to 21 days in culture increased PNMT activity in the soluble fraction of the cell. The concentration of hormone required to produce a half-maximal response was 10 nM dexamethasone when cells were cultured in the presence of 5% fetal calf serum, or 1 nM in a defined serum-free medium. These dose-response relationships are consistent with mediation of this effect by the glucocotticoid receptor. Unexpectedly, however, the glucocorticoid-induced increment in PNMT activity was not inhibited by cycloheximide at concentrations up to 50 WM, and an acceleration of protein synthesis by insulin treatment did not augment the glucocorticoid effect on PNMT. Treatment of the cells with dexamethasone (100 PM) prevented the decline in the epinephrine-to-norepinephrine ratio seen over time in culture, an effect consistent with increased PNMT activity. However, there was no effect of dexamethasone on the ability of the cells to secrete catecholamines in response to stimulation with high KCI or 30 PM nicotine. We interpret these data to suggest that PNMT activity and, thus, epinephrine biosynthesis can be controlled in cultured chromaffin cells by a mechanism which is probably tied to the glucocotticoid receptor detected in these cultures. Furthermore, these primary cultures provide a model for detailed biochemical analysis of steroid regulation of catecholamine metabolism.
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central to one of the cell's primary functions-epinephrine biosynthesis and secretion. In the rat, PNMT is subjct to dual regulation, by both glucocorticoid hormones and direct innervation via the splanchnic nerve (Ciaranello, 1977) . Glucocorticoid regulation of PNMT was demonstrated by Wurtman and Axelrod (1965 Axelrod ( , 1966 when they reported that withdrawal of endogenous glucocorticoids by hypophysectomy in the rat caused a decrease in adrenal PNMT activity. This could be reversed only by administration of high doses of replacement dexamethasone, a synthetic glucocorticoid, or by administration of ACTH. The importance of splanchnic innervation is illustrated by the fact that activation of neural input to the adrenal with 6-hydroxydopamine (Ciaranello and Black, 1971) or reserpine (Thoenen et al., 1970; Ciaranello, 1977) increases PNMT activity in rat adrenal. Berenbeim et al. (1979) have proposed that these two types of regulation, hormonal and neural, occur via distinct biochemical pathways. They suggest that glucocorticoids decrease the rate of PNMT degradation and, therefore, cause an increase in PNMT activity, whereas splanchnic nerve stimulation increases PNMT synthesis directly. Alternatively, Bohn (1983) has suggested that, although PNMT appearance during development does not depend on glucocorticoids, per se, the continued expression of the enzyme depends on maintenance of mRNA levels by glucocorticoids. It seemed possible to us that we could resolve these apparently conflicting ideas by analysis of bovine adrenal medullary chromaffin cell primary cultures. In such an in vitro system of neural crestderived cells which are less heterogeneous than those of the central nervous system, the external milieu can be controlled and biochemical processes can be easily analyzed.
In this paper, we report our studies on the influence of glucocorticoids on PNMT activity in cultures of bovine chromaffin cells. Not only were we able to replicate the in vivo finding of PNMT regulation by glucocorticoids in these cultures, but we were also able to detect an endogenous glucocorticoid receptor with an affinity in the range of physiological action of glucocorticoids on PNMT activity. These studies also suggest the potential utility of these primary cultures for investigating steroid regulation of other aspects of catecholamine metabolism.
Materials and Methods
Cell culture. Adrenal medullary ceils were isolated from 10 to 20 bovine adrenal glands that were obtained from the local slaughterhouse and kept on Ice for 1 to 2 hr. To remove blood, the glands were perfused five times by retrograde injection into the adrenal vein, using a sterile isotonic salt solution kept at 37°C. This salt solution contained 118 mM NaCI, 4.7 mM KCI, 1.2 mM MgSO,, 2.2 mM CaClz, 10 mM glucose, and 25 mM HEPES (pH 7.35). The glands were then perfused three times with a sterile solution of 0.095% collagenase (Sigma) which was dissolved in isotonic salt solution and kept at 37°C. The glands were incubated at 37°C for 15 min between perfusions. The medullae were dissected from the surrounding cortex, drained in 180. pm nylon mesh to remove red blood cells, and minced with scissors in 10 ml of the 0.095% collagenase solutron. the mean + SD of the values obtained from three wells. Where no error bars are shown, the standard deviation IS smaller than the symbol. Within the following groups of data, there were no significant differences (p < 0.01): A, days 1 to 5, days 5 and 6, days 11 to 25 8, days 2 to 5, days 11 to 25; C, days 1 to 5, days 7 to 25; D, days 2 to 5, days 12 to 25. ml of 0.095% collagenase and was shaken for 30 min at 37°C. Single ceils and cell clusters were separated from the undigested tissue by filtration through 180.pm nylon mesh and pelleted at 800 x g. The collagenase was removed from the cells by three resuspension and centrifugation cycles in the same sterile isotonic salt solution. After a frnal frltration through 180.Grn nylon mesh, the cells were resuspended in 10 to 20 ml of sterile isotonic salt containing 1% bovine serum albumin. Cells were plated in 24.well cluster tissue culture plates which had been previously coated with 15 gg of vitrogen (Grand Island Biological Co. (GIBCO))/well in Dulbecco's modified Eagle's minimal essential medium (DMEM) (GIBCO) supplemented with 5% fetal calf serum stripped of endogenous steroids. Serum was stripped by heating serum at 56°C for 30 min with 2 gm/lOO ml of activated charcoal (Sigma). The medium also contained 100 pg/ml of penicillin, 100 pg/ml of streptomycin, 5 Kg/ml of gentamicin, and 10 pg/ml of arabinosylcytosine to prevent divisron of non-chromaffin cells. The plating density was 1 x lo6 cells/well. Approximately 50% of these cells adhered to the plate after the frrst medtum change. This procedure yields a population of cells and cell clusters which are 99% viable by trypan blue exclusion and >95% positive by neutral red starning. The contamination by cortical cells, estrmated morphologically, is <5% (R. Ornberg, personal communication). Medium was changed every 3 to 4 days.
In some experiments, we used a modification of the defined medium described by Bottenstern and Sato (1979) and Wilson and Viveros (1981) . This medium contained the same additions as described above, with the following exceptrons. Standard DMEM was replaced by 50% Ham's F12 Nutrient Mix (GIBCO) and 50% DMEM in 1.5 mM HEPES (pH 7.4) containing 1.2 gm of NapCOZ/liter, and serum was omitted. Steroid treatment.
Steroids were obtained from Sigma. The appropriate aliquot of a 10 mM stock solution of each steroid in 95% ethanol was added to medium to yield the desired final concentration.
The medium was sterilized by filtration through a 0.22.pm filter and 1.5 ml were added to each culture well in place of a regular medium change. Protein synthesis studies. Protein synthesis was monrtored rn cultured cells by the addition of 2 &I of 3H-amrno acid mixture (New England Nuclear) to the standard culture medium and subsequent determination of amino acrd incorporatron into acid-precrpitable protein. At selected trmes, the cells were lysed by a freeze/thaw cycle in water, and parkculate material was removed by centrifugation in a Beckman Mrcrofuge 12 at 12,000 x g for 5 min. The supernatant was acidrfied by the addrtion of 100% TCA (frnal concentratron. lo%), the acid-preciprtable material was pelleted by centrifugation, and the amount of radroactivrty in the pellet was determined by sctntillation spectrometry. Arabinosylcytosrne was omitted from the cell culture medium in all protein synthesis experiments.
Using this method, 3H-amrno acrd rncorporation into protein was lrnear for 48 hr. Therefore, 36 hr was chosen as the standard time point for examining the effects of insulin, cycloheximrde, and glucocorticoids on protein synthesis. G/ucocort/co/d receptor brtding assay. Glucoconicoid brndrng was measured in a high speed supernatant of cultured chromafftn cells by a modifrcation of the sucrose pad/exchange assay, originally used for cytoplasmic estrogen receptor (Kelner et al., 1981) . Chromaffin cells which had been maintarned in culture for 3 days were washed three trmes with isotonic salt solution and homogenized with 10 strokes of a tight pestle In a Dounce homogenizer In 4 ml of ice-cold buffer containing 10 mM Tns, 1 mM EDTA, 10 mM sodium molybdate, 1 mM dithiothrertol, and 10% glycerol (pH 7.4). The homogenate was centrifuged at 100,000 x g for 1 hr at 4°C. Various concentratrons of (6,7-3H(N)-dexamethasone (38.0 Ci/mmol) and (6,7-3H(~)-tnamcrnolone acetonide (31.3 Ci/mmol) (New England Nuclear) were rncubated with aliquots of the supernatant at 0°C for 18 to 24 hr, conditrons which were found to be optimal for ligand binding to the glucocorticoid receptor.
Protamine sulfate precipitation was used to separate bound from free steroid. Unlabeled steroids used as competitors were purchased from Sigma. The data were analyzed by a modification of the Rosenthal resolution as described by Kelner et al. (1981) .
Catecho/am/ne measurement. Epinephrine and norepinephrine levels were determined by one of two methods. The first was a modification of the tnhydroxyindole fluorescence method of Anton and Sayre (1962) . Oxidation of alrquots of each sample at pH 7.0, a condition under which both norepinephnne and epinephrine are converted to their trrhydroxyrndole products, or at pH 2.0, a pH at which only eprnephnne IS significantly oxidized, allowed determination of the relative levels of these two catecholamines.
In some experiments, catecholamines were measured using a high performance liquid chromatography reverse phase separation (3 pm, 100 x 4.6 mm, ODS column, Chromanetics) coupled with electrochemrcal detection (ESA model This assay has been completely described and compared to the trihydroxylndole oxldatlon method previously (Kelner et al., 1985) . Statistical analyses. In experiments with two groups, the statisttcal signlficance of the data was calculated by the Student's t test. In multlple group experiments with one variable, the presence of significant differences among groups was tested by analysis of variance and, when Indicated, the slgnlficance of differences between each possible pair of points was determined by Tukey's t test using the honestly significant difference Results PNMTactivity in acute and cultured cells. PNMT activity in lysates of acutely isolated chromaffin cells was 22.6 + 1.6 (SEM) nmol/30 min/mg of protein (n = 3) or 1.04 + 0.02 nmol/30 min/106 cells (n = 3). After 2 days in culture, the activity declined to 10.8 f 0.7 nmol/30 min/mg of protein (47.9 f 8.6% of acute cell level, n = 4) or 0.58 f 0.03 nmol/30 min/106 cells (55.5 f 2.0% of acute cell level, n = 4). This drop was not due to selective plating of norepinephrine-containing cells which did not contain PNMT since the epinephrine-to-norepinephrine ratio was the same in both acute and day 1 to 3 cultured cells.
With time in culture, the specific activity of PNMT continued to fall over the course of 25 days. This is shown in figure 1, which indicates PNMT sepcific acitivity expressed as both nanomoles per 30 min per milligram of protein (Fig. 1A) and as nanomoles per 30 min per 1 O6 cells (Fig. 1 i3) , and the corresponding cell number (Fig.  IC) and soluble protein content (Fig. ID) . For the first 5 days after plating, PNMT levels expressed per milligram of protein remained constant. However, when expressed per cell, they showed a significant increase on days 2 to 5 over the levels seen on day 1 (p < 0.01). Cell number per well was also quite stable on days 1 to 5, but there was a significant rise in soluble protein on day 2 which paralleled the increase in PNMT activity per cell (p < O.Ol), perhaps reflecting cell repair after isolation. After this initial period, there was a fairly rapid decline of PNMT activity to a low, but measurable value by day 25. This was accompanied by a decrease of approximately 25% in the cell number and soluble protein levels. Nonetheless, the Since cell density has been shown to affect the levels of catecholamine biosynthetic enzymes in plated chromaffin cells (Acheson and Thoenen, 1983) , we examined the effect of cell number per well on PNMT levels in our system. As the plating density was increased, the PNMT activity per cell also increased dramatically, reaching a plateau at approximately 150,000 cells/cm* (300,000 cells/well) (data not shown). All experiments reported in this paper were performed on cells plated above a density of 150,000 cells/cm'. Glucocorticoids and PNMT activity. We tested the effect of glucocorticoids on PNMT activity in chromaffin cells cultured for various times. Addition of dexamethasone (100 PM) to the culture medium at 3, 7, or 21 days after initial plating caused an increase in PNMT specific activity, measured in the soluble fraction, of 28%, 46%, and 66% over control values, respectively. These data indicate that the cells retained responsiveness to glucocorticoids in vitro for at least 3 weeks in culture (data not shown).
Using cells cultured for 3 days, dose-response curves (1 .O nM to 100 PM) were generated with the endogenous bovine glucocorticoid, hydrocortisone, and the synthetic glucocorticoid, dexamethasone. Two types of culture media were used: standard culture medium containing 5% stripped fetal calf serum and a defined medium without serum (see "Materials and Methods"). Figures 2 and 3 illustrate the dose-response curves obtained after 2 days of incubation. In the presence of serum, hydrocortisone and dexamethasone produced broad dose-response patterns of PNMT activation, with maxima at high concentrations of hormone (100 FM for hydrocortisone and 10 FM for dexamethasone). However, in a serum-free medium, a narrower dose-response curve was seen, with increases of PNMT activity occurring at lower concentrations of hormone, approximately 1 nM, and reaching maxima at 10 to 100 nM.
The activation of PNMT by glucocorticoids required 2 days for appearance, but additional time in culture did not increase the size of the effect further (see Fig. 4 ). The magnitude of the effect was constant regardless of whether treatment was initiated on day 3 or on day 8 and remained the same at least until day 14 of culture (11 days or 6 days of treatment, respectively). The falling control value and PNMT activity in medium containing 5% fetal calf serum (left) and In serum-free defined medium (right). Plated chromaffin cells were treated exactly as described for Figure 2 , except that hydrocotiisone was substituted for dexamethasone.
Data were calculated and expressed as for Figure 2 . the standard deviation IS smaller than the symbol. Statistical analyses indicated that there were no significant differences among points in the following groups (p < 0.05): control, days 2 and 3, days 3 to 6, days 6 and 7; treated, days 3 to 6, day 10, day 14. Treated points were different from controls (p < 0.05) on day 6 and day 10. norepinephrine. The levels of the two catecholamines in acutely isolated cells were 30.9 f 2.2 nmol (SEM) of norepinephrine/106 cells (n = 6) and 63.4 ? 4.0 nmol of epinephrine/106 cells (n = 6). On day 1 of culture, these levels dropped to 56% and 48% of these values, respectively. However, during the first few days in culture, the ratio of the two catecholamines remained the same as in the acutely isolated cells (29.8% + 0.72 (SEM) norepinephrine and 70.2% + 3.08 epinephrine) (see Fig. 6 ). At these times, dexamethasone had no effect on either the absolute amount of epinephrine and norepinephrine
In the cells (cf. Fig. 6 , left and right upper pane/s) or on the relative amounts of these catecholamines (cf. Fig.  6 , left and right lower panels). With longer times in culture (more than 7 days), there was a significant drop in epinephrine levels per well, whereas norepinephrine levels remained constant (p < O.Oi), resulting in a ratio of norepinephrine to epinephrine of 52% + 3.0 (SEM):48% f 1.8 at day 17 (Fig. 6, left panels) . When the cells were maintalned in the presence of dexamethasone (Fig. 6 , right panels), there was a smaller but slgnlficant drop in epinephrine levels, as well as a drop in norepinephnne levels (p < 0.01). The ratlo of epinephrine to norepinephrine remained constant (29.5% + 0.5 (SEM) norepinephrine:70.5% + 0.5 epinephrine on day 17). Thus, dexamethasone treatment allowed the cells to maintain their initial proportions of norepinephrine and epinephnne.
We tested whether pretreatment with dexamethasone had any effect on the ability of cultured chromaffin cells to secrete catecholamines in response to secretogogues. Cells were treated with 10 PM dexamethasone acutely or for 1, 3, or 6 days. Subsequently, 30 FM nicotine or 65 mM KCI was applied to the cells for 15 min, and the norepinephrine and epinephrine released into the medium during that time period was measured by the trihydroxyindole method. For both catecholamines, basal release was less than 10% and was not affected by any dexamethasone pretreatment. Similarly, dexamethasone pretreatment of any duration had no consistent effect on the fraction of either catecholamine released into the medium with nicotine or KCI (data not shown).
Glucocorticoid receptor in chromaffin cells. Since the cultured chromaffin cells were able to respond to glucocorticoids, we examined them for the presence of a glucocorticoid receptor. Saturation analyses of high speed supernatants of cultured chromaffin cells revealed the presence of a specific saturable binding site when either 3H-dexamethasone or 3H-triamcinolone acetonide was used as ligand. A comparison of the ability of various steroids to compete for 3H-dexamethasone binding showed an order of potency of: testosterone = estradiol < progesterone << corticosterone < triamcinolone acetonide = hydrocortisone z dexamethasone (data not shown). Upper pane/, On day 5 of culture, plated chromaffin cells were treated with various concentrations of cycloheximide in the presence or absence of 100 PM dexamethasone.
After 3 days, the cells were lysed and the PNMT activity and soluble protein levels were determined as described in the text. Each point represents the mean + SEM of the values obtalned from 12 wells In two separate experiments.
There was no significant difference among the points withIn the control group or the treated group. The treated value was significantly different from control at 0, 1, and 50 PM cycloheximlde. The difference at 10 pM was not significant (In all cases p < 0.01). Lower pane/, On day 5 of culture, plated chromaffin cells were treated with various concentrattons of cycloheximide In the presence of 2 @Cl of 'H-amino acids/ well. After 36 hr, the amount of radioacWty in acid-preclpltable material was determined, as described In the text. Each point IS the mean of the values obtained from three wells
Discussion
Glucocorticoid regulation of PNMT activity in vitro. Maintenance of the levels of adrenal PNMT, the methyltransferase responsible for epinephrine synthesis, is known to depend on glucocorticoids in the rat. It was therefore reasonable to suspect that some or all of the drop in PNMT levels seen over time in cultured chromaffin cells (see Fig. 1 ) might be due to withdrawal of the cells from the endogenous source of this hormone and that replacement of glucocorticoids might restore activity. In fact, treatment of the cultured cells with the synthetic glucocorticoid, dexamethasone, or with the endogenous bovine glucocorticoid, hydrocortisone, caused a dose-dependent increase in PNMT activity when treatment was initiated at any time Kelner and Pollard Vol. 5, No. 8, Aug. 1985 Control Dexamethasone (Waymrre, 1977) and that glucocorticoids have no effect on the levels of DBH or LDH (Table I) .
In viva, the glucoconicoid-induced increase in PNMT activity requires unusually high concentrations of dexamethasone (Wurtman and Axelrod, 1966 maffin cell cultures in significant quantities. This is illustrated by the similarity of the saturation analyses obtained using ?--dexamethasone and %triamcinolone acetonide, since the second non-receptor binding site does not have an appreciable affinity for triamcinolone acetonide (Do et al., 1979) .
The mechanism of the glucocorticoid-induced increase in PNMT activity. There are several pieces of evidence that suggest that the glucocorticoid receptor mediates the glucocorticoid-induced increase in PNMT activity. Half-maximal activation of the PNMT response occurs at approximately 1 nM dexamethasone in the absence of serum. Half-maximal saturation of the receptor also occurs at this concentration of steroid, the Kd being approximately 1 nM. Both saturation of the receptor and saturation of the response occur over a dose range of two orders of magnitude. In addition, the steroid specificity of this response is identical to the steroid specificity of the receptor (Hersey and Distefano, 1979; K. L. Kelner, unpublished observation) .
The sequence of events occurring between the binding of the glucocotticoids to the receptor and the increase in PNMT activity in cultured chromaffin cells is not known, but our data may allow us to differentiate between potential mechanisms. In many systems, glucocorticoids have been shown to alter the levels of enzymes and complex on regulatory sites on the DNA. The altered levels of mRNA lead to changes in the rate of synthesis of the regulated protein. This is the mechanism proposed by Bohn (1983) for PNMT regulation by glucocorticoids. Protein synthesis inhibitors will block this type of steroid effect. For example, the hydrocortisone-induced increase in the rate of synthesis of glycerol phosphate dehydrogenase in C6 glioma cells is inhibited by 35 PM cycloheximide, as well as by RNA synthesis inhibitors (McGinnis and de Vellis, 1978) . Thus, the insensitivity of the PNMT response to 50 FM cycloheximide reported here is inconsistent with this proposed mechanism, suggesting that increased PNMT synthesis is not the cause of the elevation in activity.
Glucocorticoids are also known to increase protein degradation in muscle (Goldberg, 1969; Tomas et al., 1979) . In this regard, Ciaranello (1977) has suggested that, in the rat, the glucocorticoidinduced increase in PNMT activity is due to a slower rate of enzyme degradation. He suggests that this is caused by the protective action of increased levels of the PNMT cofactor, S-adenosylmethionine, which are a result of glucocorticoid treatment. Our data are consistent with this proposal. The amount of PNMT activity declines with time in culture, even in the presence of glucocorticoids, indicating that the rate of degradation is higher than the synthetic rate. Since protein synthesis inhibitors do not alter the glucocorticoid effect and also do not decrease the PNMT pool size (K. L. Kelner, unpublished observation), the PNMT synthetic rate must be small. Thus, the rate of degradation is the primary regulator of PNMT pool size, and a glucocorticoidinduced decrease in the rate of degradation of the enzyme would yield the results we have observed, an increase in PNMT activity. Although our data are consistent with the notion that altered protein degradation rates, rather than increased transcnption and/or translation, may mediate the glucocorticoid effect on PNMT in cultured chromaffin cells, it is also possible that it occurs by an 2168 Kelner and Pollard Vol. 5, No. 8, Aug. 1985 alternative process. 
